Evaluation of a spot-on imidacloprid-moxidectin formulation (Advocate®) for the treatment of naturally occurring esophageal spirocercosis in dogs: a double-blinded, placebo-controlled study

weekly imidacloprid and moxidectin spot-on administration may be effective for treating benign esophageal #spirocercosis, but is less effective than the currently used injectable doramectin therapy https://t.co/UqH13fSwEP